The objective of this work is to develop a closed-loop controlled insulin pump to keep the blood glucose level of Type 1 diabetes mellitus (T1DM) patients in the desired range. In contrast to the existing artificial pancreas systems with syringe pumps, an energy-efficient, valveless piezoelectric pump is designed and simulated with different types of controllers and glucose-insulin models. COMSOL Multiphysics is used for piezoelectric-fluid-structural coupled 3D finite element simulations of the pump. Then, a reduced-order model (ROM) is simulated in MATLAB/Simulink together with optimal and proportional-integral-derivative (PID) controllers and glucose-insulin models of Ackerman, Bergman, and Sorensen. Divergence angle, nozzle/diffuser dia...
International audienceInsulin, a polypeptide hormone produced by the beta-cells of the pancreas, is ...
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for...
There have been several technological advancements aimed at improving glycaemic control in people wi...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
With discovery of the insulin, Type-1 diabetes converted from a fatal and acute to a chronic disease...
Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabete...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
International audienceDiabetes is a chronic condition that occurs when the pancreas does ...
Improved glycemic control with insulin pump therapy in patients with type 1 diabetes mellitus has sh...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous health t...
To provide an understanding of both the preclinical and clinical aspects of closed-loop artificial p...
A fully implantable artificial pancreas (AP) still represents the holy grail for diabetes treatment....
The contribution of this work is the generation of a control-oriented model for insulin-glucose dyna...
Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart i...
International audienceInsulin, a polypeptide hormone produced by the beta-cells of the pancreas, is ...
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for...
There have been several technological advancements aimed at improving glycaemic control in people wi...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
With discovery of the insulin, Type-1 diabetes converted from a fatal and acute to a chronic disease...
Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabete...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
International audienceDiabetes is a chronic condition that occurs when the pancreas does ...
Improved glycemic control with insulin pump therapy in patients with type 1 diabetes mellitus has sh...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous health t...
To provide an understanding of both the preclinical and clinical aspects of closed-loop artificial p...
A fully implantable artificial pancreas (AP) still represents the holy grail for diabetes treatment....
The contribution of this work is the generation of a control-oriented model for insulin-glucose dyna...
Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart i...
International audienceInsulin, a polypeptide hormone produced by the beta-cells of the pancreas, is ...
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for...
There have been several technological advancements aimed at improving glycaemic control in people wi...